Discharge
Often, patients will still have mild wheezing, but should have complete resolution of tachypnea, hypoxia, and improved work of breathing
A short course of glucocorticoids decreases chance of relapse )
Patient should generally continue albuterol at home q6hrs for at least the first 24hrs after discharge
A spacer should be prescribed to be used with the MDI to improve medication delivery to the lungs
Admit
If symptoms do not significantly improve or for severe<unk> s
Often, patients will still have mild wheezing, but should have complete resolution of tachypnea, hypoxia, and improved work of breathing
A short course of glucocorticoids decreases chance of relapse )
Patient should generally continue albuterol at home q6hrs for at least the first 24hrs after discharge
A spacer should be prescribed to be used with the MDI to improve medication delivery to the lungs
If symptoms do not significantly improve or for severe<unk> s
Peak flow measurements maybe helpful when deciding disposition
Predicted = (30 x age (yrs)) + 30
PEF >70% predicted → high likelihood of successful discharge
PEF <40% predicted → should be admitted
Predicted = (30 x age (yrs)) + 30
PEF >70% predicted → high likelihood of successful discharge
PEF <40% predicted → should be admitted
Acute asthma exacerbation 
Upper Airway diseases
COPD exacerbation
Allergic rhinitis and sinusitis
Acute chest syndrome
Large Airway Obstruction
Acute dyspnea
Foreign body aspiration